This late-stage clinical trial company focuses on preventing inflammation and acute organ injury. It is developing a platform of new drugs to prevent inflammation in the kidneys, liver and lungs...

To read the full story on AllPennyStocks.com, click here.

Arch Biopartners (TSXV:ARCH)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Arch Biopartners.
Arch Biopartners (TSXV:ARCH)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Arch Biopartners.